Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grigory Sidorenkov

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Cancer & Metabolism|April 12, 2024
Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitusFan Zhang, Geertruida H de Bock, Gijs W Landman, et al.
Journal of Global Health|January 6, 2021
Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluationsAriuntuya Tuvdendorj, Yihui Du, Grigory Sidorenkov, et al.
Plos One|April 19, 2024
Correction: Factors associated with SARS-COV-2 positive test in LifelinesGrigory Sidorenkov, Judith M Vonk, Marco Grzegorczyk, et al.
Plos One|November 29, 2023
Factors associated with SARS-COV-2 positive test in LifelinesGrigory Sidorenkov, Judith M Vonk, Marco Grzegorczyk, et al.
Cancers|June 2, 2021
A Classification Approach for Cancer Survivors from Those Cancer-Free, Based on Health Behaviors: Analysis of the Lifelines CohortFrancisco O Cortés-Ibañez, Sunil Belur Nagaraj, Ludo Cornelissen, et al.
Diabetes, Obesity & Metabolism|April 25, 2018
HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroupsGrigory Sidorenkov, Job F M van Boven, Trynke Hoekstra, et al.
Clinical Epidemiology|January 31, 2023
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes MellitusFan Zhang, Geertruida H de Bock, Petra Denig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2025
Change in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the NetherlandsMichael Shimelash, Grigory Sidorenkov, Bert van der Vegt, et al.
Breast Cancer Research : BCR|August 27, 2025
Longitudinal changes in metabolism-related metrics and breast cancer risk: a general population studyFan Zhang, Geertruida H de Bock, Gijs W Landman, et al.
International Journal of Clinical Practice|September 20, 2016
Process quality indicators for chronic kidney disease risk management: a systematic literature reviewKirsten P J Smits, Grigory Sidorenkov, Henk J G Bilo, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Cancer & Metabolism|April 12, 2024
Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitusFan Zhang, Geertruida H de Bock, Gijs W Landman, et al.
Journal of Global Health|January 6, 2021
Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluationsAriuntuya Tuvdendorj, Yihui Du, Grigory Sidorenkov, et al.
Plos One|April 19, 2024
Correction: Factors associated with SARS-COV-2 positive test in LifelinesGrigory Sidorenkov, Judith M Vonk, Marco Grzegorczyk, et al.
Plos One|November 29, 2023
Factors associated with SARS-COV-2 positive test in LifelinesGrigory Sidorenkov, Judith M Vonk, Marco Grzegorczyk, et al.
Cancers|June 2, 2021
A Classification Approach for Cancer Survivors from Those Cancer-Free, Based on Health Behaviors: Analysis of the Lifelines CohortFrancisco O Cortés-Ibañez, Sunil Belur Nagaraj, Ludo Cornelissen, et al.
Diabetes, Obesity & Metabolism|April 25, 2018
HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroupsGrigory Sidorenkov, Job F M van Boven, Trynke Hoekstra, et al.
Clinical Epidemiology|January 31, 2023
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes MellitusFan Zhang, Geertruida H de Bock, Petra Denig, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 17, 2025
Change in Metabolic Markers and the Risk of Skin Cancer: Results from the Lifelines Cohort Study in the NetherlandsMichael Shimelash, Grigory Sidorenkov, Bert van der Vegt, et al.
Breast Cancer Research : BCR|August 27, 2025
Longitudinal changes in metabolism-related metrics and breast cancer risk: a general population studyFan Zhang, Geertruida H de Bock, Gijs W Landman, et al.
International Journal of Clinical Practice|September 20, 2016
Process quality indicators for chronic kidney disease risk management: a systematic literature reviewKirsten P J Smits, Grigory Sidorenkov, Henk J G Bilo, et al.
Pageof 9